URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Joseph Roscoe

Concepts (267)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Nausea
31
1998
155
8.700
Why?
Antineoplastic Agents
27
1998
625
4.420
Why?
Vomiting
17
1998
116
3.770
Why?
Neoplasms
30
1998
723
3.440
Why?
Acupressure
5
2002
16
2.850
Why?
Antineoplastic Combined Chemotherapy Protocols
12
1986
430
2.840
Why?
Fatigue
15
2001
125
2.540
Why?
Breast Neoplasms
19
1986
675
2.470
Why?
Antiemetics
12
1998
56
1.980
Why?
Vomiting, Anticipatory
7
1998
21
1.760
Why?
Acupuncture Therapy
4
2002
12
1.420
Why?
Sleep Disorders
4
2002
70
1.350
Why?
Doxorubicin
7
2003
109
1.160
Why?
Middle Aged
44
1986
9877
1.150
Why?
Radiotherapy
5
2002
198
1.050
Why?
Aged
35
1989
7272
1.040
Why?
Adult
35
1986
11345
0.950
Why?
Female
47
1986
19826
0.920
Why?
Humans
65
1986
36400
0.870
Why?
Depression
5
2001
431
0.850
Why?
Attitude
2
2000
64
0.840
Why?
Cisplatin
3
2000
94
0.800
Why?
Sleep
1
2011
58
0.790
Why?
Carboplatin
2
2003
30
0.730
Why?
Quality of Life
12
1998
509
0.710
Why?
Cyclohexanecarboxylic Acids
3
2003
47
0.690
Why?
Amines
3
2003
63
0.690
Why?
Wrist
3
2002
49
0.690
Why?
Cerebral Cortex
1
2011
250
0.690
Why?
gamma-Aminobutyric Acid
3
2003
98
0.670
Why?
Paroxetine
2
2003
11
0.640
Why?
Hot Flashes
2
2004
28
0.600
Why?
Fatigue Syndrome, Chronic
1
2007
10
0.590
Why?
Acetates
2
2003
65
0.580
Why?
Patient Education as Topic
6
2000
219
0.570
Why?
Serotonin Antagonists
4
1998
21
0.560
Why?
Psychophysiology
1
2006
15
0.560
Why?
Community Health Centers
2
2000
25
0.560
Why?
Aged, 80 and over
17
1989
2513
0.540
Why?
Prochlorperazine
3
2005
11
0.530
Why?
Male
31
1989
19713
0.530
Why?
Transcutaneous Electric Nerve Stimulation
1
2005
8
0.530
Why?
Therapeutic Touch
1
2005
3
0.520
Why?
Antidepressive Agents, Second-Generation
1
2005
14
0.520
Why?
Treatment Outcome
14
1998
2623
0.510
Why?
Behavior
1
2004
54
0.490
Why?
Selective Estrogen Receptor Modulators
1
2004
9
0.480
Why?
Physical Stimulation
1
2003
56
0.460
Why?
Tamoxifen
1
2004
84
0.460
Why?
Radiation Injuries
1
2005
130
0.450
Why?
Academic Medical Centers
2
2003
89
0.450
Why?
Double-Blind Method
7
2003
998
0.450
Why?
Behavior Therapy
4
1998
109
0.440
Why?
Electroacupuncture
1
2002
2
0.440
Why?
Benzhydryl Compounds
3
2005
13
0.400
Why?
Outcome Assessment (Health Care)
1
2003
293
0.380
Why?
Health Knowledge, Attitudes, Practice
3
2000
279
0.370
Why?
Severity of Illness Index
6
2000
919
0.320
Why?
Continental Population Groups
2
1997
117
0.320
Why?
Questionnaires
8
2000
998
0.320
Why?
Complementary Therapies
2
2006
36
0.320
Why?
Peritoneum
1
1997
13
0.310
Why?
Urea
1
1997
53
0.310
Why?
Kidney Failure, Chronic
2
1997
119
0.300
Why?
Peritoneal Dialysis
1
1997
20
0.300
Why?
Granisetron
2
1998
7
0.300
Why?
Adaptation, Psychological
2
2006
207
0.300
Why?
Perception
3
2004
64
0.280
Why?
Patient Satisfaction
3
2004
230
0.280
Why?
Ondansetron
2
1998
11
0.240
Why?
Risk Factors
3
2000
2318
0.240
Why?
Drug Administration Schedule
3
1989
369
0.230
Why?
Dexamethasone
2
2005
183
0.230
Why?
Relaxation Therapy
2
2007
16
0.220
Why?
Activities of Daily Living
2
2001
255
0.220
Why?
Age Factors
4
2004
1121
0.220
Why?
Quinuclidines
1
2012
5
0.220
Why?
Receptors, Neurokinin-1
1
2012
7
0.220
Why?
Intention to Treat Analysis
1
2012
10
0.220
Why?
Morpholines
1
2012
43
0.220
Why?
Pain
2
2006
382
0.220
Why?
Isoquinolines
1
2012
63
0.210
Why?
Professional Role
1
2012
22
0.210
Why?
Polysomnography
1
2011
25
0.200
Why?
Oral Health
1
2012
40
0.200
Why?
Ginger
1
2011
5
0.200
Why?
Mouth Diseases
1
2012
46
0.200
Why?
Phytotherapy
1
2011
18
0.200
Why?
Psychology, Medical
1
2011
2
0.200
Why?
Drug Therapy, Combination
1
2012
390
0.200
Why?
Cyclophosphamide
3
2003
173
0.200
Why?
Suggestion
1
2010
7
0.190
Why?
Benzodiazepines
1
2010
26
0.190
Why?
Self Efficacy
1
2011
44
0.190
Why?
Conditioning, Classical
1
2010
33
0.190
Why?
Receptors, Serotonin, 5-HT3
3
1998
8
0.190
Why?
Dentate Gyrus
1
2010
26
0.180
Why?
Central Nervous System Stimulants
1
2010
42
0.180
Why?
Clinical Trials as Topic
4
1989
675
0.180
Why?
Serotonin 5-HT3 Receptor Antagonists
2
2004
7
0.180
Why?
Information Seeking Behavior
1
2009
3
0.180
Why?
Pilot Projects
3
2004
441
0.180
Why?
Hypnosis
2
2006
16
0.180
Why?
Information Services
1
2009
22
0.170
Why?
Diabetes Mellitus, Type 2
1
2012
225
0.170
Why?
Community Health Services
2
2006
77
0.170
Why?
Insulin-Like Growth Factor I
1
2010
106
0.170
Why?
Blood-Brain Barrier
1
2010
108
0.170
Why?
Sleep Initiation and Maintenance Disorders
1
2009
45
0.170
Why?
Placebos
2
2005
182
0.170
Why?
Adolescent
6
1989
4752
0.170
Why?
Gene Expression Regulation, Neoplastic
1
2011
254
0.170
Why?
Awareness
1
2008
35
0.160
Why?
Pregnancy
2
2002
1962
0.160
Why?
Cognition Disorders
1
2011
278
0.150
Why?
Sickness Impact Profile
1
2007
40
0.150
Why?
Stress, Psychological
1
2011
283
0.150
Why?
Survivors
2
2004
114
0.150
Why?
Young Adult
2
2009
1074
0.150
Why?
Cognition
1
2009
227
0.150
Why?
Incidence
1
2009
679
0.140
Why?
Placebo Effect
1
2006
34
0.140
Why?
Administration, Oral
2
2003
309
0.140
Why?
Acupuncture Points
1
2005
2
0.140
Why?
Serotonin
2
2001
99
0.140
Why?
Choice Behavior
1
2006
47
0.130
Why?
Menopause
1
2005
43
0.130
Why?
Models, Psychological
1
2006
90
0.130
Why?
Motion Sickness
1
2004
8
0.130
Why?
Sex Factors
3
1997
584
0.130
Why?
Tai Ji
1
2004
22
0.120
Why?
Chronic Disease
1
2007
530
0.120
Why?
Exercise
1
2006
182
0.120
Why?
Analysis of Variance
4
2003
725
0.120
Why?
Decision Making
1
2006
224
0.120
Why?
Serotonin Uptake Inhibitors
1
2003
35
0.120
Why?
Combined Modality Therapy
1
2005
486
0.110
Why?
Demography
3
2006
97
0.110
Why?
Receptors, Serotonin
2
1998
12
0.110
Why?
New England
1
2002
24
0.110
Why?
Pregnancy Complications
1
2004
196
0.110
Why?
Cross-Over Studies
1
2002
126
0.110
Why?
Peritoneal Dialysis, Continuous Ambulatory
1
2001
6
0.100
Why?
Affect
1
2001
78
0.100
Why?
Health Surveys
3
2004
198
0.100
Why?
Patients
1
2001
47
0.100
Why?
Circadian Rhythm
1
2001
85
0.100
Why?
Reference Values
1
2002
441
0.100
Why?
Time Factors
5
1986
3201
0.090
Why?
Multivariate Analysis
1
2002
531
0.090
Why?
Ovarian Neoplasms
1
2000
107
0.080
Why?
Self-Assessment
2
2006
52
0.080
Why?
Regression Analysis
1
2000
524
0.080
Why?
Follow-Up Studies
4
1989
1857
0.080
Why?
Diabetic Nephropathies
1
1997
22
0.080
Why?
Permeability
1
1997
82
0.080
Why?
Asian Continental Ancestry Group
1
1997
30
0.080
Why?
Carcinoma
1
1999
191
0.080
Why?
Patient Acceptance of Health Care
2
2008
113
0.080
Why?
Weight Loss
2
2004
75
0.070
Why?
Biological Transport
1
1997
389
0.070
Why?
African Continental Ancestry Group
1
1997
121
0.070
Why?
Animals
2
2010
16270
0.070
Why?
Prostatic Neoplasms
1
2002
556
0.070
Why?
Ethnic Groups
1
1997
146
0.070
Why?
Palliative Care
1
1998
159
0.070
Why?
Social Support
2
2004
228
0.070
Why?
Physician-Patient Relations
3
2000
365
0.070
Why?
Longitudinal Studies
2
2005
390
0.070
Why?
United States
3
2006
2630
0.070
Why?
European Continental Ancestry Group
1
1997
226
0.070
Why?
Attitude to Health
2
2006
209
0.060
Why?
Prevalence
2
2002
541
0.060
Why?
Dose-Response Relationship, Drug
2
2001
1138
0.060
Why?
General Practice
1
2012
1
0.050
Why?
New York
2
2006
1282
0.050
Why?
Directive Counseling
1
2012
5
0.050
Why?
Dentistry
1
2012
18
0.050
Why?
Patient Preference
1
2012
9
0.050
Why?
Qualitative Research
1
2012
55
0.050
Why?
Self Care
1
2012
60
0.050
Why?
Indiana
1
2011
6
0.050
Why?
Massage
1
2011
9
0.050
Why?
Interviews as Topic
1
2012
181
0.050
Why?
Factor Analysis, Statistical
1
2011
57
0.050
Why?
Interleukin-8
1
2011
111
0.050
Why?
Patient Care Team
1
2012
194
0.050
Why?
Bromodeoxyuridine
1
2010
67
0.050
Why?
Energy Metabolism
1
2011
137
0.050
Why?
Neurogenesis
1
2010
30
0.050
Why?
Chemokine CCL2
1
2011
128
0.050
Why?
Fluorouracil
1
2010
76
0.050
Why?
Paclitaxel
1
2010
57
0.040
Why?
Psychometrics
1
2011
221
0.040
Why?
Outpatients
1
2009
32
0.040
Why?
Glomerulonephritis, Membranous
1
1989
2
0.040
Why?
Confidence Intervals
1
2009
165
0.040
Why?
Memory
1
2009
102
0.040
Why?
Interleukin-6
1
2011
340
0.040
Why?
Needs Assessment
1
2009
92
0.040
Why?
Health Behavior
1
2009
102
0.040
Why?
Health Services Needs and Demand
1
2009
104
0.040
Why?
Prednisone
1
1989
177
0.040
Why?
Odds Ratio
1
2009
304
0.040
Why?
National Cancer Institute (U.S.)
1
2007
12
0.040
Why?
Attention
1
2009
148
0.040
Why?
Reproducibility of Results
1
2011
884
0.040
Why?
Quality Indicators, Health Care
1
2007
55
0.040
Why?
Cognitive Therapy
1
2007
40
0.040
Why?
Sulfinpyrazone
1
1986
2
0.040
Why?
Argininosuccinic Acid
1
1986
3
0.040
Why?
Mitomycins
1
1986
17
0.040
Why?
Plasmapheresis
1
1986
25
0.040
Why?
National Institutes of Health (U.S.)
1
2006
63
0.040
Why?
Cancer Care Facilities
1
2006
9
0.030
Why?
Cell Proliferation
1
2010
521
0.030
Why?
Radiotherapy, Adjuvant
1
2006
73
0.030
Why?
Chemotherapy, Adjuvant
1
2006
88
0.030
Why?
Program Evaluation
1
2006
205
0.030
Why?
Arginine
1
1986
119
0.030
Why?
Electric Stimulation Therapy
1
2005
28
0.030
Why?
Radiation Dosage
1
2005
126
0.030
Why?
Alopecia
1
2004
20
0.030
Why?
Mice, Inbred C57BL
1
2010
1683
0.030
Why?
Antidepressive Agents
1
2005
93
0.030
Why?
Acute Disease
1
2005
580
0.030
Why?
Psychotherapy
1
2005
87
0.030
Why?
Self Concept
1
2004
103
0.030
Why?
Educational Status
1
2004
172
0.030
Why?
Blood Platelets
1
1986
280
0.030
Why?
Glucocorticoids
1
2005
166
0.030
Why?
Randomized Controlled Trials as Topic
1
2005
409
0.030
Why?
Communication
1
2006
271
0.030
Why?
Chi-Square Distribution
1
2003
333
0.030
Why?
Psychiatric Status Rating Scales
1
2003
333
0.030
Why?
Hospitals, Chronic Disease
1
2001
2
0.030
Why?
Neurons
1
2010
1108
0.030
Why?
Ontario
1
2001
11
0.030
Why?
Behavioral Medicine
1
2001
11
0.030
Why?
Peritonitis
1
2001
34
0.030
Why?
Infection
1
2001
67
0.030
Why?
Health Status Indicators
1
2002
108
0.030
Why?
Vagus Nerve
1
2001
40
0.020
Why?
Pituitary-Adrenal System
1
2001
36
0.020
Why?
Autonomic Nervous System
1
2001
70
0.020
Why?
Hypothalamo-Hypophyseal System
1
2001
55
0.020
Why?
Catheters, Indwelling
1
2001
70
0.020
Why?
Anemia
1
2001
77
0.020
Why?
Sampling Studies
1
2000
47
0.020
Why?
Professional-Patient Relations
1
2000
45
0.020
Why?
Breast Neoplasms, Male
1
1999
6
0.020
Why?
Informed Consent
1
2000
82
0.020
Why?
Adenosine Triphosphate
1
2001
414
0.020
Why?
Data Collection
1
2000
214
0.020
Why?
Mice
1
2010
6103
0.020
Why?
Emetics
1
1998
4
0.020
Why?
Cytokines
1
2001
572
0.020
Why?
Creatinine
2
1986
132
0.020
Why?
Sensitivity and Specificity
1
2000
905
0.020
Why?
Retrospective Studies
1
2001
2260
0.020
Why?
Proteinuria
1
1989
29
0.010
Why?
Random Allocation
1
1989
254
0.010
Why?
Tablets, Enteric-Coated
1
1986
2
0.010
Why?
Dipyridamole
1
1986
10
0.010
Why?
Mitomycin
1
1986
18
0.010
Why?
Prospective Studies
1
1989
1677
0.010
Why?
Adenocarcinoma
1
1986
423
0.010
Why?

Visualizations


Roscoe's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department